2026-06-14T03:37:43Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/154602025-05-07T10:58:41Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608col_20.500.12105_19609

00925njm 22002777a 4500 dc Bagaria, Jayshree author Jansen, Tessa author Marques, Diogo FP author Hooiveld, Mariëtte author McMenamin, Jim author de Lusignan, Simon author Vilcu, Ana-Maria author Meijer, Adam author Rodrigues, Ana Paula author Brytting, Mia author Mazagatos, Clara author Cogdale, Jade author van der Werf, Sylvie author Dijkstra, Frederika author Guiomar, Raquel author Enkirch, Theresa author Valenciano, Marta author I-MOVE-COVID-19 study team author Larrauri, Amparo author Pozo Sanchez, Francisco author Casas Flecha, Inmaculada author 2022-06 As the COVID-19 pandemic began in early 2020, primary care influenza sentinel surveillance networks within the Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE) consortium rapidly adapted to COVID-19 surveillance. This study maps system adaptations and lessons learned about aligning influenza and COVID-19 surveillance following ECDC / WHO/Europe recommendations and preparing for other diseases possibly emerging in the future. Using a qualitative approach, we describe the adaptations of seven sentinel sites in five European Union countries and the United Kingdom during the first pandemic phase (March-September 2020). Adaptations to sentinel systems were substantial (2/7 sites), moderate (2/7) or minor (3/7 sites). Most adaptations encompassed patient referral and sample collection pathways, laboratory testing and data collection. Strengths included established networks of primary care providers, highly qualified testing laboratories and stakeholder commitments. One challenge was the decreasing number of samples due to altered patient pathways. Lessons learned included flexibility establishing new routines and new laboratory testing. To enable simultaneous sentinel surveillance of influenza and COVID-19, experiences of the sentinel sites and testing infrastructure should be considered. The contradicting aims of rapid case finding and contact tracing, which are needed for control during a pandemic and regular surveillance, should be carefully balanced. Euro Surveill. 2022 Jun;27(26):2100864. 10.2807/1560-7917.ES.2022.27.26.2100864 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 35775429 http://hdl.handle.net/20.500.12105/15460 COVID-19 Europe Influenza-Like Illness (ILI) SARS-CoV-2 Sentinel surveillance Primary care Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned